The special programme for Investigator Initiated Clinical Trials (IICTs) of the Swiss National Science Foundation (SNSF) supports clinical trials as defined in the Federal Act on Research involving Human Beings (Human Research Act, HRA)* and regulated by the Ordinance on Clinical Trials in Human Research (Clinical Trials Ordinance, ClinO)**. These trials address a documented unmet medical need and are of value to the patients but not in industry focus.
Excluded from support through IICT programme are:
Non-randomized and uncontrolled studies
Pilot studies, proof of concept studies
Animal studies, preclinical studies
Studies with safety endpoints only
Observational studies
Physiological, pathophysiological studies and technology developments without prospective allocation to a health-related intervention
Studies involving healthy subjects
Studies conducted for direct commercial purposes
* Clinical trial means a research project in which persons are prospectively assigned to a health-related intervention** in order to investigate its effects on health or on the structure and function of the human body.